ANTIPODES PARTNERS Ltd

All 13F Filings

Location
Royal Exchange, C3
Most recent 13F
Q4 2025
Holdings value ($000)
4,762,381
Description
Royal Exchange based planning integrated investment advisor with a regulated corporate organization and a high accountability and controls oriented investment mandate. The approach emphasizes valuation discipline and downside awareness, fundamental research depth, and active stewardship and governance oversight for private client and family mandates. Portfolio governance emphasizes clear accountability, measured exposure, and resilient implementation through manager selection governance and portfolio discipline.
Website
Founded
Chairman
CEO
All SEC filings
View on sec.gov

Sector allocation over time (stocks only)

Stacked by quarter. Hover to see detailed sector breakdown for any quarter.

Quarter Date Filed Holdings Value ($000) Form Type Name
Q4 2025 2/5/2026 130 4,762,381 13F-HR ANTIPODES PARTNERS Ltd
Q3 2025 11/10/2025 116 4,457,269 13F-HR ANTIPODES PARTNERS Ltd
Q2 2025 8/5/2025 106 3,224,241 13F-HR ANTIPODES PARTNERS Ltd
Q1 2025 5/6/2025 103 3,193,098 13F-HR ANTIPODES PARTNERS Ltd
Q4 2024 2/10/2025 79 2,877,723 13F-HR ANTIPODES PARTNERS Ltd
Q3 2024 11/14/2024 84 2,885,206 13F-HR ANTIPODES PARTNERS Ltd
Q2 2024 8/5/2024 80 2,752,884 13F-HR ANTIPODES PARTNERS Ltd
Q1 2024 5/7/2024 72 3,161,719 13F-HR ANTIPODES PARTNERS Ltd
Q4 2023 1/24/2024 72 3,201,864 13F-HR ANTIPODES PARTNERS Ltd
Q3 2023 11/13/2023 69 3,112,366 13F-HR ANTIPODES PARTNERS Ltd
Q2 2023 7/25/2023 69 2,896,851 13F-HR ANTIPODES PARTNERS Ltd
Q1 2023 5/11/2023 69 2,885,556 13F-HR ANTIPODES PARTNERS Ltd
Q4 2022 2/8/2023 69 2,787,616 13F-HR ANTIPODES PARTNERS Ltd
Q3 2022 11/10/2022 44 2,491,781 13F-HR ANTIPODES PARTNERS Ltd
Q2 2022 8/12/2022 42 2,400,889 13F-HR ANTIPODES PARTNERS Ltd
Q1 2022 4/21/2022 37 2,820,308 13F-HR ANTIPODES PARTNERS Ltd
Q4 2021 6/7/2022 36 2,783,297 13F-HR/A - NEW HOLDINGS ANTIPODES PARTNERS Ltd
Q4 2021 4/21/2022 37 2,835,401 13F-HR/A - NEW HOLDINGS ANTIPODES PARTNERS Ltd
Q4 2021 2/14/2022 35 2,824,304 13F-HR ANTIPODES PARTNERS Ltd
Q3 2021 11/15/2021 34 2,925,603 13F-HR ANTIPODES PARTNERS Ltd
Q2 2021 8/17/2021 30 2,773,212 13F-HR ANTIPODES PARTNERS Ltd
Q1 2021 5/13/2021 30 2,468,818 13F-HR ANTIPODES PARTNERS Ltd
Q4 2020 2/16/2021 32 2,300,035 13F-HR ANTIPODES PARTNERS Ltd
Q3 2020 11/10/2020 34 2,183,010 13F-HR ANTIPODES PARTNERS Ltd
Q2 2020 7/30/2020 32 2,208,595 13F-HR ANTIPODES PARTNERS Ltd
Q1 2020 5/7/2020 33 1,910,849 13F-HR ANTIPODES PARTNERS Ltd
Q4 2019 2/5/2020 30 2,219,956 13F-HR ANTIPODES PARTNERS Ltd
Swipe for more columns
Money flow by instrument (QoQ, ex-options)
Type Value ($000) Share % Inflow Outflow Net
Stocks 4.761 M 100.0% 305.7 K 0 305.7 K
Swipe for more columns

Fund Snapshot

Q4 2025
Latest filed
2/5/2026
Total value ($000)
4,762,381
Holdings
130
QoQ value change ($000)
305,112 (6.8%)
Value = total reported 13F value ($000), Holdings = number of positions.
13F Value over time
Holdings count over time
Sector allocation (latest, stocks only)
Methodology: sector allocation is stocks-only; instrument flow table is ex-options; options exposure is shown separately. Details.